bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.02.03.636333

C3H-HeN as a TLR4 competent mouse model of sublethal leptospirosis

Abstract

AbstractMice are slowly being accepted as alternative models for investigation of leptospiral infection. The strain most used to analyse sublethal disease (C3H-HeJ) expresses a tlr4 gene in its immune cells that is hyporesponsive to leptospiral LPS and thus the model is deemed immunocompromised. To help resolve this valid scientific concern we did a study in which we compared infection with Leptospira interrogans serovar Copenhageni Fiocruz in mice expressing fully competent tlr4 (C3H-HeN, C57BL6) versus tlr4 hyporesponsive mice (C3H- HeJ) over a period of two weeks. We found that the C3H-HeJ mouse was the only strain that sustained lethal infection, thus confirming the association between tlr4 function and acute disease. We found that the two mouse strains with a fully functional tlr4 gene (C3H-HeN and C57BL/6) also developed clinical and molecular signs of sublethal leptospirosis nearly on par with C3H-HeJ, as quantified by weight loss, survival curves, presence of Leptospira 16S rRNA in blood and urine, and burden of viable spirochetes in kidney. Regarding kidney markers of inflammation and fibrosis, C3H-HeN and C57BL/6 produced less IL-1 beta, iNOS and ColA1 than C3H-HeJ, which is consistent with increased resilience to infection expected of the tlr4 competent strains. Regarding Leptospira-specific antibody, all mouse strains produced IgM and T-cell independent IgG3. Interestingly, in contrast to C57BL/6, both C3H strains produced circulating IgG1 but only C3H-HeN produced IgG2a to L. interrogans two weeks post infection. Thus, TLR4-competent C3H-HeN and C57BL/6 may be more appropriate mouse models of sublethal leptospirosis, whereas C3H-HeJ can be used to further establish a mouse model of lethal leptospirosis. Our data strongly suggests that TLR4 function is important but not sufficient to cause susceptibility to leptospirosis. Author summaryPrevious studies by different laboratories have shown C3H-HeJ to be a susceptible mouse strain to sublethal and lethal leptospirosis. The goal of our study was to evaluate if low tlr4 responsiveness to leptospiral LPS in C3H-HeJ mice is the factor that drives susceptibility to infection with pathogenic Leptospira. We did a comparative study using mouse strains immunocompetent and hyporesponsive to tlr4. The data shows that although tlr4 does affect the virulence of leptospirosis (only C3H-HeJ succumbed to infection), the tlr4 competent strains (C3H-HeN and C57BL/6) also developed measurable sublethal leptospirosis. Thus, competent recognition of leptospiral-LPS by murine TLR4 plays a role but it is not sufficient to determine susceptibility to leptospirosis. Furthermore, the data suggests that T-cell dependent responses could be involved in susceptibility to leptospirosis in the C3H models of infection.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Abil, O. Z., Kundu, S., Midon, L. M., Gomes-Solecki, M.. 2025-02-03. C3H-HeN as a TLR4 competent mouse model of sublethal leptospirosis. https://doi.org/10.1101/2025.02.03.636333

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗